Mark Ballantyne

Partner
Full contact info

I love the challenges of working with technology and life sciences companies as they evolve from startups to public companies.

Passions

Golfing

Traveling

Experience

Lexeo Therapeutics Announces $100 Million IPO

November 3, 2023

Cooley advised Lexeo Therapeutics, a clinical-stage gene therapy company advancing gene therapy candidates for genetically defined cardiovascular diseases and a genetically defined subgroup of Alzheimer’s disease, on its approximately $100 million initial public offering.

Read more

Related contacts

Eric Blanchard
Partner, New York
Peter Byrne
Partner, New York
Div Gupta
Partner, New York
Ivor Elrifi
Partner, New York
Matthew Pavao
Partner, Boston
Xander Lee
Partner, Los Angeles Santa Monica
Barbara Mirza
Partner, Los Angeles Santa Monica
Aaron Pomeroy
Partner, Colorado
Phil Mitchell
Partner, New York
Mark Ballantyne
Partner, Reston
Francis Wheeler
Partner, Colorado
Natasha Leskovsek
Of Counsel, Washington DC
Stephanie Parker Palmer
Special Counsel, Reston
Joseph Lockinger
Special Counsel, Washington DC
Christophe Beauduin
Special Counsel, New York
Randy Sabett
Special Counsel, Washington DC
Jennifer Shanley
Special Counsel, New York
Reid Hooper
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Dayne Brown
Associate, New York
Ibe Alozie
Associate, Washington DC
Christopher Nickas
Associate, New York
DeVon Barnett
Associate, Washington DC
Carly Robinson
Associate, Reston
Calvin Lee
Associate, New York
Jayne M. Munger
Associate, New York
Megan Drill
Associate, San Diego
Erika Freeman
Associate, New York
Mor Agam
Associate, New York
Wyatt Kernell
Associate, New York
Wyatt Kernell
Associate, New York
Alexander Fullman
Associate, New York
Zimu Yang
Associate, Washington DC
Jason Minio
Paralegal Specialist, Boston
Andrew Henderson
Patent Agent, Seattle

Related Practices & Industries

Cardlytics Enters Cooperation Agreement With CAS Investment Partners

September 19, 2023

Cooley advised Cardlytics, an advertising platform in banks’ digital channels, on its cooperation agreement with CAS Investment Partners, a 14.4% stockholder of Cardlytics.

Read more

Related contacts

Mark Ballantyne
Partner, Reston
Miguel J. Vega
Partner, Boston
Bill Roegge
Partner, New York
James Lin
Associate, New York
Trey Reilly
Associate, New York
William DuVal
Associate, Reston
Jacob Grosso
Associate, Reston

Related Practices & Industries

Cooley Advises on MindMed’s Successful Proxy Contest

June 21, 2023

Cooley advised MindMed, a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, on its successful proxy contest against FCM MM Holdings.

Read more

Related contacts

Bill Roegge
Partner, New York
Christian Plaza
Partner, Reston
Mark Ballantyne
Partner, Reston
Kenneth Guernsey
Senior Counsel , San Francisco
Sarah Lightdale
Partner, New York
Kaitland Kennelly
Partner, New York
Megan Arthur Schilling
Partner, San Diego
Aric Wu
Partner, New York
Dayne Brown
Associate, New York
Amanda L. Liverzani
Associate, New York
Andrew Mettry
Associate, Chicago
Natasha Patel
Associate, New York
Dionne A. Thomas
Associate, San Diego
Charlotte Yin
Associate, New York

Related Practices & Industries

Structure Therapeutics – $185.3 Million IPO

February 9, 2023

San Francisco – February 9, 2023 Cooley advised Structure Therapeutics, a clinical-stage global biopharmaceutical company, on its $185.3 million initial public offering, including the full exercise of the underwriters’ option to purchase additional American depositary shares. Lawyers Charlie Kim, Patrick Loofbourrow, Andrew Harline and Su Lian Lu led the Cooley team.

The offering marks the first sizable US life sciences IPO this year. Structure Therapeutics will use the proceeds to develop new oral therapies for the treatment of various diseases, including those impacting the metabolic, cardiovascular and pulmonary systems. Its lead product candidate targets Type 2 diabetes and obesity.

Structure Therapeutics aims to develop and deliver novel oral therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages structure-based drug discovery and computational chemistry expertise, enabling it to build a pipeline of product candidates. The company currently focuses on G-protein-coupled receptors as a therapeutic target class.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has nearly 1,400 lawyers across 18 offices in the United States, Asia and Europe, and a total workforce of more than 3,000.

Related contacts

Charlie Kim
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Andrew Harline
Partner, Singapore
Su Lian Lu
Special Counsel, Los Angeles Santa Monica
Xander Lee
Partner, Los Angeles Santa Monica
Jie Zhang
Partner, Hong Kong
Phil Mitchell
Partner, New York
Aaron Pomeroy
Partner, Colorado
Carlos Ramirez
Partner, San Diego
Ryan Blair
Partner, San Diego
Joshua Mates
Partner, San Francisco
Mark Ballantyne
Partner, Reston
Nicola Squire
Partner, London
Francis Wheeler
Partner, Colorado
Will Cai
Partner, Hong Kong
Thomas Welk
Senior Counsel, San Diego
Natasha Leskovsek
Of Counsel, Washington DC
Dani Nazemian
Special Counsel, San Diego
Randy Sabett
Special Counsel, Washington DC
Bin Wang
Special Counsel, Palo Alto
Rebecca Ross
Special Counsel, Washington DC
Lisa Yuan
Special Counsel, Beijing
Jennifer Shanley
Special Counsel, New York
Christine Turner
Associate, Colorado
Vince Flynn
Associate, San Diego
Ivy Wang
Associate, Shanghai
Rick Jantz
Associate, Los Angeles Santa Monica
Yuan Dai
Associate, Shanghai
Cara Buchicchio
Associate, New York
Megan Drill
Associate, San Diego
Daniel Gillon
Associate, San Diego
Dionne A. Thomas
Associate, San Diego
Cristina Ferruolo
Associate, San Diego
Brian Lau
International Legal Project Manager, Hong Kong
Jessica Wade
Paralegal Specialist, San Diego
Kate Walther
Paralegal Specialist, San Diego
Lunga Su
Associate, Shanghai
Christine S. Kim
Associate, San Diego
Andy Zachrich
Associate, San Diego

Related Practices & Industries

BigCommerce Holdings – $345 Million Convertible Senior Notes Offering

September 15, 2021

Cooley advised the initial purchasers on BigCommerce Holding’s offering of $345 million aggregate principal amount of 0.25% Convertible Senior Notes due 2026. Morgan Stanley, Goldman Sachs and BofA Securities acted as joint book-running managers for the offering. BigCommerce, whose securities trade on the Nasdaq Global Market under the symbol BIGC, is a leading software-as-a-service ecommerce platform. Partners Nicole Brookshire, Mischi a Marca, Jason Savich and Darren Destefano led the Cooley team.

Related contacts

Mischi a Marca
Partner, San Francisco
Jason Savich
Partner, San Francisco
Darren DeStefano
Partner, Reston
Ellie Guadiana
Partner, Los Angeles Santa Monica
Mark Ballantyne
Partner, Reston
Asheley Walker
Associate, Washington DC
Molly Niffenegger
Associate, San Francisco
Jennifer Don
Associate, Reston

Related Practices & Industries

View more

Rankings & accolades

Best Lawyers: Ones to Watch - Securities/Capital Markets Law and Venture Capital Law (2021)